The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria.

2024年1月14日 · This article explains what the FDA 2 is, its protocol, categories, scoring protocol, and other equipment needed to implement it. Comprehension of the FDA 2 is indispensable for speech pathologists but also for interdisciplinary clinical teams working with the diagnosis and management of patients presenting with dysarthric symptomatology.

Frenchay构音障碍评定量表第二版（FDA-2: Frenchay Dysarthria Assessment-Second Edition）。 第二版的Frenchay构音障碍评估( FDA-2 )，包括了关于运动性言语障碍的新的强有力的知识更新，以及其对神经诊

Updated FDA 2nd edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria; Accurate, reliable, and cost-efficient, for use in international research, as well as all clinical settings; Norms provided for ages 12 to 97

2008年1月1日 · FDA-2 is quick and simple to administer, accurate, reliable, and cost-efficient. The client is rated on a number of simple performance tasks related to speech function. It is divided into eight sections: 1. Reflexes — Ratings for cough, swallow, and dribble/drool 2. Respiration — Ratings at rest and in speech 3.

The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria.

2018年10月23日 · Rapid SARS-CoV-2 Antigen Test Card, 1 Pack, 8 Tests Total, FDA EUA Authorized OTC at-Home Self Test, Results in 15 Minutes, Convenient and Comfortable to use

2008年1月1日 · Ages: 12 years to adult Testing Time: 20 minutes Administration: Individual The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis.

FDA-2 includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria. It can be used in research, as well as all clinical settings.?

The second edition of frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological...